Key facts
- CustomSurg’s last known valuation is $9.6M (Dec 2023).
- It has raised $4.2M; the latest was Later Stage VC ($1.0M) in Dec 2025.
- Notable investors include Venture Kick, High-Tech Gründerfonds, Innosuisse, Kickfund, East Coast Fund Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for CustomSurg
- ·The full record, as it builds
Funding rounds
No funding rounds for CustomSurg are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CustomSurg
Developer of fracture-specific bone plates designed to treat bone fractures and related issues. The company leverages computer tomography and three-dimensional printing to match bone plates to the individual patient's anatomy to provide improved stability, enabling healthcare providers to reduce surgery time and cut long-term healthcare costs for patients.
- Sector
- Healthcare
- HQ
- Zurich, Switzerland
- Founded
- 2014
- Employees
- 6
- Website
- customsurg.com/
- Ownership
- Privately Held (backing)
CustomSurg doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CustomSurg shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CustomSurg in its N-PORT filings yet. We sweep new filings monthly.